(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in the prefilled syringe fill finish manufacturing market include an increased demand for safer, user-friendly administration technologies, a trend toward outsourcing fill/finish operations, and significant growth potential in Asia-Pacific regions. The market benefits from growing self-medication trends and technological advancements.

Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Prefilled Syringe Fill Finish Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapeutic Area, Type of Syringe Barrel Material, Number of Barrel Chambers, Type of Drug Molecule and Key Geographical Regions" report has been added to ResearchAndMarkets's offering.

The global prefilled syringe fill finish manufacturing market valued at USD 931 million in 2025, is anticipated to grow at a lucrative CAGR of 11.9% during 2025-2035

Fundamentally, a prefilled syringe is a single dose of medication, containing a pre-measured amount of injectable. It is used as a primary drug container for injectable drugs and vaccines. Some of the categories of drugs packaged in prefilled syringes include blood stimulants, erythropoietin products, interferons and therapeutic proteins.

Over the past ten years, with the increase in development of parenteral drugs, the usage of prefilled syringes has tripled. Notably, these prefilled syringes offer several advantages over traditional drug delivery systems (such as vials and syringes), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. As a result, prefilled syringes are preferably being used in the delivery of injectable drugs, especially in the treatment of chronic diseases (requiring repeated administration of the medications).

The numerous benefits offered by prefilled syringes, coupled with the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations. Moreover, owing to a number of operational challenges, such as the requirement of technical expertise associated with close monitoring and control of syringe fill volume, the market has witnessed a shift in trend towards outsourcing of the fill / finish operations for prefilled syringes.

Additionally, the current demand for safer, easier to use administration technologies along with the industry's efforts to reduce costs and increase efficiency are expected to drive the growth of the prefilled syringe fill finish manufacturing market in future.

Prefilled Syringe Fill Finish Manufacturing Market: Key Insights

• Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.
• The market landscape features the presence of well-established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.
• Over 55% of the companies have the capabilities to offer fill / finish services for both small molecules and biologics; ~20% of the companies are offering these services for only biologics.
• In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.
• Several contract service providers (~60), including AMRI, Catalent Biologics, Pierre Fabrre and Sandoz offer fill / finish services at both clinical and commercial scale of operation.
• Although most industry stakeholders are based in the developed regions, fill / finish operations in Asian countries, such as India, Taiwan and Bangladesh, are emerging.
• Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.
• As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.
• An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.
• Around 70 prefilled syringes are being manufactured by large companies, most of which claim to be capable of fabricating syringe barrels from both glass and plastic materials.
• We expect drug developers to continue to outsource their fill / finish operations in the short to midterm, resulting in an annualized growth at the rate of over 11.9% within the contract services market.
• In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.
• With an increasing demand for prefilled syringes and focus on user-friendly systems, the market opportunity is projected to evolve at a rapid pace in the coming years.

Prefilled Syringe Fill Finish Manufacturing Market: Research Coverage

• Capacity Analysis: An in-depth analysis of contract fill / finish capacity of prefilled syringes, examining factors, such as company size of manufacturer, scale of operation, location of headquarters and fill / finish facilities and type of drug molecule.
• Demand Analysis: A detailed analysis of the current and future demand for fill / finish of prefilled syringes, based on various parameters, such as marketed drugs available, target patient population, dosing frequency, dose strength, geography, type of drug molecule, therapeutic area, syringe barrel material and number of barrel chambers.
• Geographical Assessment of Demand and Supply: An insightful geographical analysis of demand and supply, based on several parameters, such as number of prefilled syringe combination product developers, number of prefilled syringe manufacturers, number of prefilled syringe fill / finish service providers, number of prefilled syringe fill / finish facilities, and capacity and demand for prefilled syringes in that particular geographical region.
• Likely Partner Analysis: A detailed analysis of the potential strategic partners for prefilled syringe fill / finish service providers, based on various parameters, such as developer strength, pipeline strength, type of drug molecule, target therapeutic area and location of the headquarters of the company.
• Case Study 1: A detailed discussion on the potential areas of growth, such as growing injectable drugs pipeline, increasing popularity of prefilled syringes, rise in preference for outsourcing of fill / finish operations, technological advancements in aseptic fill / finish processes and growing opportunities in the Asia-Pacific region.
• Case Study 2: Elaborate assessment of prefilled syringe manufacturers landscape, based on a number of relevant parameters, such as syringe barrel material, number of barrel chambers, type of needle system, barrel volume, year of establishment and location of the headquarters of manufacturers.

Reasons to Buy this Report

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Report Scope:

Players in the Prefilled Syringe Fill Finish Manufacturing Market Profiled in the Report

• Ajinomoto Bio-Pharma Services
• AMRI
• BioPharma Solutions
• Emergent BioSolutions
• Patheon (a Thermo Fisher Scientific Company)
• Consort Medical
• EVER Pharma
• GlaxoSmithKline
• IDT Biologika
• Rentschler Biopharma
• Siegfried
• Vetter Pharma
• Biocon
• Intas Pharmaceuticals
• Kemwell Biopharma
• Square Pharmaceuticals.

Type of Therapeutic Area

• Blood Disorders
• Infectious Diseases
• Metabolic Disorders
• Oncology Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

Type of Syringe Barrel Material

• Glass
• Plastic

Number of Barrel Chambers

• Single Chamber
• Dual Chamber

Type of Drug Molecule

• Biologic
• Small Molecule

Scale of Operation

• Commercial
• Preclinical / Clinical

Key Geographical Regions

• North America
• Europe
• Asia- Pacific

Additional Benefits

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachments

• List of PPS Fill Finish Service Providers
• Location of Manufacturing
• Number of Barrel Chambers

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN01102025004107003653ID1110134568